Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status

Investigative and Clinical Urology ◽

10.4111/icu.2016.57.5.357 ◽

2016 ◽

Vol 57 (5) ◽

pp. 357 ◽

Author(s):

Yasuhiro Kaiho ◽

Shinichi Yamashita ◽

Akihiro Ito ◽

Yoshihide Kawasaki ◽

Hideaki Izumi ◽

...

Keyword(s):

Radical Prostatectomy ◽

Phosphodiesterase Type 5 Inhibitor ◽

Continence Status ◽

Incontinence Pads ◽

Phosphodiesterase Type

Download Full-text

Penile rehabilitation protocol after robot-assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency

BJU International ◽

10.1111/j.1464-410x.2009.08820.x ◽

2010 ◽

Vol 105 (3) ◽

pp. 382-388 ◽

Author(s):

Daniel J. Lee ◽

Philippa Cheetham ◽

Ketan K. Badani

Keyword(s):

Radical Prostatectomy ◽

Inhibitor Therapy ◽

Robot Assisted ◽

Rehabilitation Protocol ◽

Phosphodiesterase Type 5 Inhibitor ◽

Phosphodiesterase Type ◽

Assessment Of Compliance ◽

Penile Rehabilitation

Download Full-text

MP45-08 PHOSPHODIESTERASE TYPE 5 INHIBITOR (PDE5I) USE AFTER RADICAL PROSTATECTOMY (RP) IS NOT ASSOCIATED WITH INCREASED RISK OF BIOCHEMICAL RECURRENCE RISK (BCR)

The Journal of Urology ◽

10.1097/ju.0000000000000900.08 ◽

2020 ◽

Vol 203 ◽

pp. e667-e668

Author(s):

Lawrence Jenkins* ◽

James Eastham ◽

Vincent Laudone ◽

Peter Scardino ◽

Christian Nelson ◽

...

Keyword(s):

Radical Prostatectomy ◽

Biochemical Recurrence ◽

Recurrence Risk ◽

Phosphodiesterase Type 5 Inhibitor ◽

Increased Risk ◽

Phosphodiesterase Type

Download Full-text

Phosphodiesterase Type 5 Inhibitor Use Following Radical Prostatectomy is not Associated with an Increased Risk of Biochemical Recurrence

Annals of Surgical Oncology ◽

10.1245/s10434-015-5059-1 ◽

2015 ◽

Vol 23 (5) ◽

pp. 1760-1767 ◽

Author(s):

Jung Ki Jo ◽

Kwangmo Kim ◽

Sang Eun Lee ◽

Jung Keun Lee ◽

Seok-Soo Byun ◽

...

Keyword(s):

Radical Prostatectomy ◽

Biochemical Recurrence ◽

Phosphodiesterase Type 5 Inhibitor ◽

Increased Risk ◽

Phosphodiesterase Type

Download Full-text

Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy

BJU International ◽

10.1111/j.1464-410x.2012.11168.x ◽

2012 ◽

Vol 110 (11c) ◽

pp. E931-E938 ◽

Author(s):

Masaki Kimura ◽

Jorge R. Caso ◽

Lionel L. Bañez ◽

Bridget F. Koontz ◽

Leah Gerber ◽

...

Keyword(s):

Radical Prostatectomy ◽

Rehabilitation Programme ◽

Successful Outcome ◽

Phosphodiesterase Type 5 Inhibitor ◽

Phosphodiesterase Type ◽

Vacuum Erection Device ◽

Penile Rehabilitation

Download Full-text

Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis

Andrology ◽

10.1111/andr.12403 ◽

2017 ◽

Vol 5 (5) ◽

pp. 863-872 ◽

Author(s):

E. Limoncin ◽

G. L. Gravina ◽

G. Corona ◽

M. Maggi ◽

G. Ciocca ◽

...

Keyword(s):

Systematic Review ◽

Radical Prostatectomy ◽

Erectile Function ◽

Sequential Analysis ◽

Randomized Trials ◽

Trial Sequential Analysis ◽

Nerve Sparing ◽

Phosphodiesterase Type 5 Inhibitor ◽

Function Recovery ◽

Phosphodiesterase Type

Download Full-text

Penile rehabilitation protocol after robot-assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency

Yearbook of Urology ◽

10.1016/s0084-4071(10)79471-9 ◽

2010 ◽

Vol 2010 ◽

pp. 189-190

Author(s):

A. Shindel

Keyword(s):

Radical Prostatectomy ◽

Inhibitor Therapy ◽

Robot Assisted ◽

Rehabilitation Protocol ◽

Phosphodiesterase Type 5 Inhibitor ◽

Phosphodiesterase Type ◽

Assessment Of Compliance ◽

Penile Rehabilitation

Download Full-text

Sexual Rehabilitation After Nerve-Sparing Radical Prostatectomy: Free-of-Charge Phosphodiesterase Type 5 Inhibitor Administration Improves Compliance to Treatment

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2017.12.011 ◽

2018 ◽

Vol 15 (2) ◽

pp. 120-123 ◽

Author(s):

Giampaolo Siena ◽

Andrea Mari ◽

Aude Canale ◽

Nicola Mondaini ◽

Andrea Chindemi ◽

...

Keyword(s):

Radical Prostatectomy ◽

Nerve Sparing ◽

Sexual Rehabilitation ◽

Phosphodiesterase Type 5 Inhibitor ◽

Compliance To Treatment ◽

Phosphodiesterase Type

Download Full-text

A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy

European Urology ◽

10.1016/j.eururo.2015.02.002 ◽

2015 ◽

Vol 68 (5) ◽

pp. 750-753 ◽

Author(s):

Andrea Gallina ◽

Marco Bianchi ◽

Giorgio Gandaglia ◽

Vito Cucchiara ◽

Nazareno Suardi ◽

...

Keyword(s):

Radical Prostatectomy ◽

Detailed Analysis ◽

Biochemical Recurrence ◽

Phosphodiesterase Type 5 Inhibitor ◽

Phosphodiesterase Type

Download Full-text

Editorial Comment to Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy

International Journal of Urology ◽

10.1111/j.1442-2042.2012.03163.x ◽

2012 ◽

Vol 20 (4) ◽

pp. 419-420

Author(s):

Mauro Gacci

Keyword(s):

Radical Prostatectomy ◽

Editorial Comment ◽

Urinary Continence ◽

Nerve Sparing ◽

Phosphodiesterase Type 5 Inhibitor ◽

Phosphodiesterase Type

Download Full-text

Impact of postoperative phosphodiesterase type 5 inhibitor treatment on lower urinary tract symptoms after robot-assisted radical prostatectomy: a longitudinal study

Scandinavian Journal of Urology ◽

10.1080/21681805.2016.1250810 ◽

2016 ◽

Vol 51 (1) ◽

pp. 33-37 ◽

Author(s):

Masashi Honda ◽

Bunya Kawamoto ◽

Shuichi Morizane ◽

Katsuya Hikita ◽

Kuniyasu Muraoka ◽

...

Keyword(s):

Longitudinal Study ◽

Urinary Tract ◽

Radical Prostatectomy ◽

Lower Urinary Tract ◽

Robot Assisted ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Inhibitor Treatment ◽

Download Full-text